Home
Solutions
Quality
Dexur Predictions and Guidance
Dexur Simulations
Dexur AI Quality Advisor
Dexur Scorecards, Measures and Data Classes
Dexur Goal Setting
Evidence Based Quality
Dexur AI Risk Factor Identification
Quality Best Practices
Dexur’s Quality Measure Reporting
Dexur’s AI Medical Coding Auditor
Dexur’s Clinical Peer Review
Safety, Risk & Incidents
Patient Safety Incident Management
Employee Incident Management
Infrastructure Incident Management
Our Focus
CMS Star Ratings
Hospital Acquired Infections
Readmissions & Mortalities
HCAHPS Patient Experience
Leapfrog
CMS VBP
MSPB
Who We Serve
Independent Hospitals
Rural & Critical Access Hospitals
Hospital Associations
Systems & IDNs
Payors
Life Sciences Organizations
Resources
Star Rating Predictions By State
Readmissions & Mortality Predictions by State
Find Your Hospital’s Quality Guidance
Customers & Partners
Dexur ROI Benefit
Dexur Hospital Insights
Dexur Rural Health Insights
White Papers & Posters Page
Articles
Dexur Videos
About Us
Pricing
Login
ICD 10 Diagnosis Code
ICD 9 Diagnosis Code
ICD 10 Procedure Code
ICD 9 Procedure Code
DRG
Search
Examples:
ICD M32
,
ICD R6521
,
ICD 8210
,
ICD 1970
Home
140-239
230-234
230 to 234 - ICD 9 Diagnosis Code - Carcinoma In Situ - Market Size, Prevalence, Incidence, Quality Outcomes, Top Hospitals & Physicians
ICD Code
Description
230
Carcinoma in situ of digestive organs
231
Carcinoma in situ of respiratory system
232
Carcinoma in situ of skin
233
Carcinoma in situ of breast and genitourinary system
234
Carcinoma in situ of other and unspecified sites